Luye Pharma Group Ltd. (LYPHF) AI-Powered Stock Analysis
See how Luye Pharma Group Ltd. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
LYPHF●PNK
HealthcareDrug Manufacturers - General
$0.33
$0.00(0.00%)
U.S. Market opens in 52h 49m
Advertisement
Luye Pharma Group Ltd. (LYPHF)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerLuye Pharma Group Ltd. (LYPHF) Stock Overall Grade
Luye Pharma Group Ltd.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Luye Pharma Group Ltd.'s overall stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
BScore
67/100Key Ratios
AScore
84/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Luye Pharma Group Ltd. (LYPHF) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (67/100, B) highlight its stability, while Key Ratios (84/100, A) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Luye Pharma Group Ltd. stock grade, including financials, comparisons, and forecasts.